BridgeBio Pharma Ownership | Who Owns BridgeBio Pharma?

Overview Forecast RevenueFinancials Chart Transcripts

BridgeBio Pharma Ownership Summary

BridgeBio Pharma is owned by 97.89% institutional investors, 3.92% insiders. Vanguard group is the largest institutional shareholder, holding 8.85% of BBIO shares. Blue Owl Credit Income Corp D is the top mutual fund, with 3.89% of its assets in BridgeBio Pharma shares.

BBIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	BridgeBio Pharma	97.89%	3.92%	-1.81%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	16.86M	8.85%	$1.29B
Kohlberg kravis roberts	13.26M	6.72%	$984.76M
Janus henderson group	13.18M	6.68%	$978.61M
Blackrock	12.45M	6.64%	$315.31M
Viking global investors lp	11.84M	6.00%	$879.42M
Blackrock funding, inc. /de	10.29M	5.28%	$766.19M
Farallon capital management	9.37M	4.75%	$695.48M
Vanguard capital management	7.90M	4.06%	$588.32M
Aisling capital management lp	4.59M	2.36%	$341.83M
Invesco	4.59M	2.33%	$341.06M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aisling capital management lp	4.59M	72.48%	$341.83M
Kohlberg kravis roberts	13.26M	18.42%	$984.76M
Catalio capital management, lp	432.01K	6.70%	$32.08M
Frazier life sciences management	3.45M	6.59%	$256.06M
Cutter capital management, lp	560.34K	6.30%	$15.38M
First turn management	695.72K	5.77%	$51.66M
Boone capital management	228.83K	5.21%	$16.99M
Superstring capital management lp	88.66K	4.54%	$4.60M
Farallon capital management	9.37M	3.96%	$695.48M
Knott david m jr	92.85K	3.66%	$6.92M

Top Buyers

Holder	Shares	% Assets	Change
Citadel advisors	3.17M	0.04%	2.48M
Janus henderson group	13.18M	0.49%	2.18M
Blackrock	12.45M	0.01%	1.98M
Norges bank	1.69M	0.01%	1.69M
Jane street group	1.76M	0.02%	1.42M

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	10.29M	0.01%	-3.92M
Brooklands fund management	-	-	-2.75M
Viking global investors lp	11.84M	2.46%	-2.55M
Macquarie group	-	-	-1.93M
Geode capital management	3.42M	0.01%	-1.50M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.69M	0.01%	1.69M	$126.15M
T. rowe price investment management	1.05M	0.03%	1.05M	$54.63M
Public sector pension investment board	103.00K	0.02%	103.00K	$7.67M
Catalyst funds management pty	94.30K	0.39%	94.30K	$7.02M
Point72 europe (london) llp	89.46K	0.23%	89.46K	$4.65M

Sold Out

Holder	Change
Tortoise investment management	-1.00
Dv trading	-1.00
Central trust	-2.00
Td private client wealth	-2.00
Dunhill financial	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	483	1.90%	193,076,305	1.05%	97	0.97%	262	1.16%	138	-
Dec 31, 2025	140	-67.21%	32,651,635	-82.36%	17	0.18%	86	-61.78%	32	-76.30%
Sep 30, 2025	144	-63.36%	28,301,584	-85.01%	14	0.15%	78	-65.64%	46	-57.80%
Jun 30, 2025	392	13.29%	188,775,960	1.99%	99	1.05%	226	14.14%	109	32.93%
Mar 31, 2025	344	12.05%	185,144,507	4.79%	97	1.11%	196	24.05%	82	5.13%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Blue Owl Credit Income Corp D	7.62M	3.89%	7.62M
Vanguard Total Stock Mkt Idx Inv	5.60M	2.86%	42.48K
Vanguard Morn Total Stk Mkt Idx Investor	5.60M	2.86%	42.48K
Vanguard US Total Market Shares ETF	4.53M	2.38%	3.92K
Vanguard Small Cap Index	4.04M	2.06%	28.04K
iShares Russell 2000 ETF	3.80M	1.94%	35.05K
Vanguard Health Care Inv	2.64M	1.35%	2.64M
SPDR® S&P Biotech ETF	2.40M	1.26%	5.36K
Vanguard Small Cap Growth Index Inv	2.33M	1.19%	74.55K
Vanguard Morn Small Cap Growth Index Inv	2.33M	1.19%	74.55K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 30, 2026	Apuli Maricel	Chief Accounting Officer	Sell	$160.12K
Jul 09, 2026	Ellis Andrea	-	Sell	$1.44M
Jul 09, 2026	Cook Jennifer E.	-	Sell	$3.04M
Jul 09, 2026	Cook Jennifer E.	-	Sell	$10.12M
Jun 23, 2026	Cook Jennifer E.	-	Sell	$150.58K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	52
2026 Q1	-	50
2025 Q4	-	50
2025 Q3	-	35
2025 Q2	-	16

BBIO Ownership FAQ

Who Owns BridgeBio Pharma?

BridgeBio Pharma shareholders are primarily institutional investors at 97.89%, followed by 3.92% insiders and -1.81% retail investors. The average institutional ownership in BridgeBio Pharma's industry, Biotech Stocks , is 35.43%, which BridgeBio Pharma exceeds.

Who owns the most shares of BridgeBio Pharma?

BridgeBio Pharma’s largest shareholders are Vanguard group (16.86M shares, 8.85%), Kohlberg kravis roberts (13.26M shares, 6.72%), and Janus henderson group (13.18M shares, 6.68%). Together, they hold 22.26% of BridgeBio Pharma’s total shares outstanding.

Does Blackrock own BridgeBio Pharma?

Yes, BlackRock owns 6.64% of BridgeBio Pharma, totaling 12.45M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 315.31M$. In the last quarter, BlackRock increased its holdings by 1.98M shares, a 18.93% change.

Who is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested, with 72.48% of its assets in 4.59M BridgeBio Pharma shares, valued at 341.83M$.

Who is the top mutual fund holder of BridgeBio Pharma shares?

Blue Owl Credit Income Corp D is the top mutual fund holder of BridgeBio Pharma shares, with 3.89% of its total shares outstanding invested in 7.62M BridgeBio Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools